Related Experiment Video

Updated: Jul 14, 2026

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

Adenovirus-mediated small hairpin RNA targeting Bcl-XL as therapy for colon cancer

Hongbo Zhu1, Yuping Zhu, Jingzi Hu

  • 1Department of Colorectal Surgery, Sir Run Run Shaw Hospital, Zhejiang University, Zhejiang, China.

International Journal of Cancer
|May 31, 2007
PubMed

Insights

This study shows that an adenovirus carrying small hairpin RNA (shRNA) effectively targets Bcl-XL, an anti-cancer protein, in colon cancer cells. This approach reduced tumor growth in mice without harming normal tissues, supporting its potential as a colon cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Bcl-XL, an anti-apoptotic protein, is frequently overexpressed in colon cancers.
  • Targeting Bcl-XL presents a potential therapeutic strategy for colon cancer treatment.

Purpose of the Study:

  • To evaluate the feasibility of using a recombinant adenovirus expressing small hairpin RNA (shRNA) against Bcl-XL (Ad/Bcl-XL shRNA) as a colon cancer therapy.
  • To assess the in vivo efficacy of Ad/Bcl-XL shRNA in reducing colon cancer cell viability and tumor growth.

Main Methods:

  • Construction of a recombinant adenovirus encoding U6 promoter-driven shRNA targeting Bcl-XL.
  • Evaluation of Ad/Bcl-XL shRNA's ability to induce RNA interference and apoptosis in colon cancer cells and tumors.
  • Assessment of tumor growth suppression in a nude mouse model using Ad/Bcl-XL shRNA.

Main Results:

  • Ad/Bcl-XL shRNA effectively reduced Bcl-XL expression and decreased colon cancer cell viability.
  • Treatment with Ad/Bcl-XL shRNA significantly increased the cleavage of apoptosis-related enzymes (caspase-9, caspase-3, PARP).
  • Ad/Bcl-XL shRNA suppressed subcutaneous tumor growth in vivo without apparent toxicity to normal tissues.

Conclusions:

  • Adenovirus-mediated RNA interference targeting Bcl-XL is a feasible therapeutic approach for colon cancer.
  • Further studies are warranted to investigate the safety and efficacy of this gene therapy for colon cancer treatment.

More Related Videos

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA04:29

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA

Published on: November 1, 2024

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...